PCGF3-FANCI Fusion FISH Probe
The PCGF3-FANCI Fusion FISH Probe is used to confirm a fusion of the PCGF3 and FANCI genes. The fusion of the PCGF3 and FANCI genes has been associated with Lung Squamous Cell Carcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| PCGF3-FANCI-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| PCGF3-FANCI-20-RERE | 20 (40 μL) | 200 μL |
|
|
| PCGF3-FANCI-20-REOR | 20 (40 μL) | 200 μL |
|
|
| PCGF3-FANCI-20-REGO | 20 (40 μL) | 200 μL |
|
|
| PCGF3-FANCI-20-REGR | 20 (40 μL) | 200 μL |
|
|
| PCGF3-FANCI-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| PCGF3-FANCI-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| PCGF3-FANCI-20-OROR | 20 (40 μL) | 200 μL |
|
|
| PCGF3-FANCI-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| PCGF3-FANCI-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| PCGF3-FANCI-20-GORE | 20 (40 μL) | 200 μL |
|
|
| PCGF3-FANCI-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| PCGF3-FANCI-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| PCGF3-FANCI-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| PCGF3-FANCI-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| PCGF3-FANCI-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| PCGF3-FANCI-20-GROR | 20 (40 μL) | 200 μL |
|
|
| PCGF3-FANCI-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| PCGF3-FANCI-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| PCGF3-FANCI-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| PCGF3-FANCI-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| PCGF3-FANCI-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| PCGF3-FANCI-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| PCGF3-FANCI-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| PCGF3-FANCI-20-AQAQ | 20 (40 μL) | 200 μL |
|
PCGF3 Gene Summary
The protein encoded by this gene contains a C3HC4 type RING finger, which is a motif known to be involved in protein-protein interactions. The specific function of this protein has not yet been determined. [provided by RefSeq, Jul 2008]
Gene Name: Polycomb Group Ring Finger 3
Chromosome: CHR4: 699572 -764427
Locus: 4p16.3
FANCI Gene Summary
The Fanconi anemia complementation group (FANC) currently includes FANCA, FANCB, FANCC, FANCD1 (also called BRCA2), FANCD2, FANCE, FANCF, FANCG, FANCI, FANCJ (also called BRIP1), FANCL, FANCM and FANCN (also called PALB2). The previously defined group FANCH is the same as FANCA. Fanconi anemia is a genetically heterogeneous recessive disorder characterized by cytogenetic instability, hypersensitivity to DNA crosslinking agents, increased chromosomal breakage, and defective DNA repair. The members of the Fanconi anemia complementation group do not share sequence similarity; they are related by their assembly into a common nuclear protein complex. This gene encodes the protein for complementation group I. Alternative splicing results in two transcript variants encoding different isoforms. [provided by RefSeq, Jul 2008]
Gene Name: Fanconi Anemia Complementation Group I
Chromosome: CHR15: 89787193 -89860362
Locus: 15q26.1
Gene Diseases
The PCGF3 FANCI Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Lung Squamous Cell Carcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|